ORG Partners’s Quest Diagnostics DGX Stock Holding History

ORG Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$36.6K	Buy	211 +84	+66%	+$15.3K	0.01%	647
2025 Q3	$24.3K	Buy	127 +35	+38%	+$6.21K	﹤0.01%	754
2025 Q2	$16.6K	Buy	92 +31	+51%	+$5.38K	﹤0.01%	801
2025 Q1	$10.4K	Buy	61 +2	+3%	+$329	﹤0.01%	791
2024 Q4	$8.95K	Buy	59 +9	+18%	+$1.4K	﹤0.01%	915
2024 Q3	$7.82K	Hold	50	–	–	﹤0.01%	830
2024 Q2	$6.9K	Hold	50	–	–	﹤0.01%	1322
2024 Q1	$6.74K	Buy	+50	New	+$6.49K	0.01%	317
2023 Q4	–	Sell	-50	Closed	-$6.57K	–	1100
2023 Q3	$6.11K	Sell	50 -2,511	-98%	-$335K	﹤0.01%	915
2023 Q2	$359K	Buy	+2,561	New	+$353K	0.06%	278

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ORG Partners's DGX Position: Q4 2025 in Review

ORG Partners increased its Quest Diagnostics (DGX) stake by 66% in Q4 2025, buying an estimated $15.3K and bringing the position to 211 shares worth $36.6K. The position accounts for 0.01% of the portfolio, ranked #647.

ORG Partners first reported a position in DGX in Q2 2023 and has held it in 10 quarters since. The position peaked at $359K in Q2 2023. 1,048 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

ORG Partners held 211 shares of Quest Diagnostics worth $36.6K as of Q4 2025.
ORG Partners bought 84 Quest Diagnostics shares in Q4 2025, an estimated $15.3K.
Quest Diagnostics made up 0.01% of ORG Partners's portfolio in Q4 2025, its #647 holding.
ORG Partners first reported a position in Quest Diagnostics in Q2 2023 and has held it in 10 quarters since.
ORG Partners's Quest Diagnostics position peaked at $359K in Q2 2023.
1,048 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.